THE USE OF PROBIOTIC BACTERIA CAPABLE OF PROMOTING THE DEVELOPMENT OF AN EARLY BIFIDOGENIC INTESTINAL MICROBIOTA IN THE MANUFACTURE OF A MEDICAMENT OR THERAPEUTIC NUTRITIONAL COMPOSITION FOR REDUCING THE RISK OF DEVELOPMENT OF OVERWEIGHT OR OBESITY OF AN INFANT LATER IN LIFE.